STAT
JULY 9, 2024
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men and 10 women who came to a sprawling medical campus in downtown Buffalo, N.Y., to volunteer for what a news report had billed as “the world’s biggest science project.
PharmaVoice
JULY 9, 2024
Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 9, 2024
The overdose crisis is claiming lives across the United States, but it reaches new depths of despair in the criminal justice system. Overdose is the leading cause of death among people returning to their communities after being in jail or prison. Providing addiction treatment in these settings could change that. Roughly 60% of people who are incarcerated have a substance use disorder, in many cases an opioid use disorder.
PharmaVoice
JULY 9, 2024
Recent history suggests an Alzheimer’s approval doesn’t necessarily translate to market triumph. Perhaps for Eli Lilly’s Kisunla, this time could be different.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
STAT
JULY 9, 2024
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in the pharmaceutical supply chain — wield such “enormous power” that these companies can affect the ability of many Americans to access and afford their medicines. The agency noted that the three largest PBMs processed nearly 80% of the roughly 6.6 billion prescriptions dispensed by U.S. pharmacies in 2023.
BioPharma Dive
JULY 9, 2024
The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals but also some notable setbacks during his time as Pfizer’s top scientist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Welltopia Pharmacy
JULY 9, 2024
Vitamin D3 Foods play a crucial role in ensuring optimal health by providing a vital nutrient that supports bone strength, immune function, and overall well-being. Vitamin D3, also known as cholecalciferol, is one of the most crucial nutrients for maintaining optimal health.
STAT
JULY 9, 2024
Five years ago — before the pandemic — Pfizer’s head of research and development, Mikael Dolsten, told STAT he kept a chess set in his office that he got as a gift from a former CEO of the company. It was a memento delivered to Dolsten after he cautioned his boss that research and development was a long process, like a chess match, not something that would happen quickly.
European Pharmaceutical Review
JULY 9, 2024
Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The team tested various samples two ion chromatography analytical methods. This included a range of water types eg, purified and potable water, according to the paper. Kumar et al. explained that “accurate determination of nitrite content in process water will support an understanding of the potential for nitrosamine formation from nitrite in process water
STAT
JULY 9, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. STAT published an investigation this morning on the untold story of the Human Genome Project and ethics concerns surrounding the ambitious project. Check it out here.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
JULY 9, 2024
Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer
STAT
JULY 9, 2024
Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are affected by neurological disorders such as Alzheimer’s disease and other dementias, stroke, migraine, depression, anxiety, neonatal encephalopathy, and more. Efforts to expand research that can lead to new and more effective treatments for neurological diseases are sorely needed.
Pharma Times
JULY 9, 2024
The serious, progressive kidney disease affects nearly 850 million people worldwide
STAT
JULY 9, 2024
WASHINGTON — A Massachusetts man has regained his voice after surgeons removed his cancerous larynx and, in a pioneering move, replaced it with a donated one. Transplants of the so-called voice box are extremely rare, and normally aren’t an option for people with active cancer. Marty Kedian is only the third person in the U.S. ever to undergo a total larynx transplant – the others, years ago, because of injuries – and one of a handful reported worldwide.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
JULY 9, 2024
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […] Source
Express Pharma
JULY 9, 2024
Novo Holdings announces that it has co-led a £90 million ($114 million) Series A financing for Myricx Bio, the largest European biotech Series A financing this year. Myricx Bio is a UK biotech company focusing on the discovery and development of a novel payload class for antibody-drug conjugates (ADCs). The funds will be used to advance Myricx’s proprietary pipeline of N-Myristoyltransferase inhibitor (NMTi) ADCs through clinical proof of concept, targeting clinically validated tumour-associat
pharmaphorum
JULY 9, 2024
After languishing in the doldrums for a few quarters, there are signs that the winds of investment are starting to blow again in the US digital health sector.
The Pharmacist
JULY 9, 2024
The Department of Health and Social Care has confirmed the appointment of two new ministers – one for health and one for social care. Karin Smyth, MP for Bristol South for almost 10 years and previously a non-executive director of a primary care trust, will take on the role as minister of state for health. […] The post Health and social care ministers appointed appeared first on The Pharmacist.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JULY 9, 2024
A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear. The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.
Express Pharma
JULY 9, 2024
Lupin announced that it has received tentative approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release (ER) Tablets, 5 mg/2.5 mg/1,000 mg, 10 mg/5 mg/1,000 mg, 12.5 mg/2.5 mg/1,000 mg, and 25 mg/5 mg/1,000 mg, to market a generic equivalent of Trijardy XR Extended-Release Tablets, 5 mg/2.5 mg/1,000 mg, 10 mg/5 mg/1,000 mg, 12.5 mg/2.5 mg/1,000 mg, and 25 mg/5 mg/1,000 mg, of
Drug Patent Watch
JULY 9, 2024
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […] Source
Express Pharma
JULY 9, 2024
The US Food and Drug Administration aims to advance its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to maintain and improve their health. The agency is providing updated recommendations to empower industry seeking to voluntarily address misinformation about or related to their approved/cleared medical products.
pharmaphorum
JULY 9, 2024
Learn about the opportunity costs of gene therapies like Beqvez. Discover the obstacles and potential paths forward in the evolving field of gene therapy.
Express Pharma
JULY 9, 2024
Johnson & Johnson announced that the USFood and Drug Administration (FDA) has issued traditional approval for SIRTURO (bedaquiline) as part of combination therapy in adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampicin and isoniazid.
The Pharmacist
JULY 9, 2024
A coroner investigating an overdose death has raised ‘grave concerns’ about online drug sales, including the lack of communication with a patient’s GP. The same case suggested failings in communication between hospital and community pharmacy, which the coroner said she was satisfied have since been resolved. 'Huge' quantity of drugs bought online Last month, coroner […] The post Coroner investigates death after 'huge' quantity of drugs bought online appeared first on The Pharmaci
Drug Patent Watch
JULY 9, 2024
The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models.
pharmaphorum
JULY 9, 2024
In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.
Express Pharma
JULY 9, 2024
Bengaluru recently bore a severe water crisis, and its scars are fresh for those whose lives were upended. From the hush in school corridors to the solemn whispers of hospital wards, from the hurried rituals of crematoriums to the humble routines of household chores, and the fading rumble of factories, the spectre of a city drying out haunts our collective consciousness.
Outsourcing Pharma
JULY 9, 2024
In an in-depth interview with Liza Laws, Senior Editor of Outsourcing-Pharma (OSP), Tim Martin, a key figure at YSEOP, shared insights on the company's recent advancements and activities in AI and drug discovery, and how their solutions are transforming the pharmaceutical industry.
pharmaphorum
JULY 9, 2024
Roche will reintroduce its Susvimo implant wet AMD, which was withdrawn from sale in 2022 due to manufacturing defects.
Outsourcing Pharma
JULY 9, 2024
Her grandmother was in a marching band in the early 1900s and mom was only ond of two in her graduating class as a pharmacist and her dad, an inventor with more than 30 patents.
BioPharma Dive
JULY 9, 2024
The biotech’s stock rose more than 60% as fresh data appeared to alleviate some investor concerns about the therapy’s effectiveness and reliability.
Outsourcing Pharma
JULY 9, 2024
dsm-firmenich has announced the launch of CBtru â an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.
Expert insights. Personalized for you.
363 
Let's personalize your content